M&T Bank Corp Emergent Bio Solutions Inc. Transaction History

M&T Bank Corp

$30.1 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$27.42 - $43.63 $274,282 - $436,430	-10,003 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$36.48 - $52.22 $189,841 - $271,752	-5,204 Reduced 34.22%	10,003 $412,000
Q4 2021 Feb 07, 2022	BUY	$33.11 - $55.01 $14,667 - $24,369	443 Added 3.0%	15,207 $661,000
Q3 2021 Oct 28, 2021	SELL	$50.07 - $66.05 $14,019 - $18,494	-280 Reduced 1.86%	14,764 $739,000
Q2 2021 Aug 13, 2021	SELL	$56.61 - $80.46 $210,759 - $299,552	-3,723 Reduced 19.84%	15,044 $948,000
Q1 2021 May 06, 2021	BUY	$86.23 - $125.19 $3,018 - $4,381	35 Added 0.19%	18,767 $1.74 Million
Q4 2020 Feb 12, 2021	BUY	$79.17 - $111.47 $254,927 - $358,933	3,220 Added 20.76%	18,732 $1.68 Million
Q3 2020 Nov 06, 2020	SELL	$81.91 - $134.94 $300,609 - $495,229	-3,670 Reduced 19.13%	15,512 $1.6 Million
Q2 2020 Jul 29, 2020	SELL	$54.33 - $89.52 $257,469 - $424,235	-4,739 Reduced 19.81%	19,182 $1.52 Million
Q1 2020 May 14, 2020	BUY	$49.34 - $68.76 $10,262 - $14,302	208 Added 0.88%	23,921 $1.38 Million
Q4 2019 Feb 07, 2020	SELL	$51.21 - $59.06 $127,052 - $146,527	-2,481 Reduced 9.47%	23,713 $1.28 Million
Q3 2019 Nov 12, 2019	BUY	$40.6 - $57.2 $134,995 - $190,190	3,325 Added 14.54%	26,194 $1.37 Million
Q2 2019 Aug 12, 2019	SELL	$39.92 - $53.86 $332,773 - $448,976	-8,336 Reduced 26.71%	22,869 $1.11 Million
Q1 2019 May 15, 2019	BUY	$48.23 - $66.16 $31,397 - $43,070	651 Added 2.13%	31,205 $1.58 Million
Q4 2018 Feb 01, 2019	BUY	$55.63 - $73.24 $351,748 - $463,096	6,323 Added 26.09%	30,554 $1.81 Million
Q3 2018 Nov 09, 2018	SELL	$52.05 - $66.51 $11,451 - $14,632	-220 Reduced 0.9%	24,231 $1.6 Million
Q2 2018 Aug 10, 2018	SELL	$48.33 - $55.64 $97,626 - $112,392	-2,020 Reduced 7.63%	24,451 $1.23 Million
Q1 2018 May 04, 2018	BUY	$44.44 - $54.39 $150,162 - $183,783	3,379 Added 14.63%	26,471 $1.39 Million
Q4 2017 Feb 06, 2018	BUY	$37.77 - $47.75 $164,299 - $207,712	4,350 Added 23.21%	23,092 $1.07 Million
Q2 2017 Aug 11, 2017	BUY	N/A	18,742	18,742 $635,000

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$34.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$30.1 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$22.1 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$19.7 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$17 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $442M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account